Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He is currently finishing up a Master’s degree in communications at Georgetown University.

Latest Posts

The Hill: Will Support for Biomedical Research Be Dead on Arrival?

ebola

In an op-ed over at The Hill, Dr. Claire Pomeroy, an infectious disease specialist and president of the Albert and Mary Lasker Foundation, discusses an important question: “How is it that the United States, which has historically held the global lead in medical innovation, was caught flat-footed by Ebola?” Dr. Pomeroy points to a lack of federal funding for medical research as one of the primary culprits for our lack of effective Ebola answers, a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Bavarian Nordic CEO Paul Chaplin in San Jose Mercury News: Why an Ebola Vaccine Still Matters

ebola

The San Jose Mercury News this weekend published an op-ed by Paul Chaplin, the CEO of Bavarian Nordic and a co-chair of the Alliance for Biosecurity which discussed the continuing need to develop an Ebola vaccine – as well as continued federal investments in the programs which fund such research. As Dr. Chaplin notes, all of the Ebola drug and vaccine candidates currently in development have received U.S. federal funding. Why do medical countermeasures against Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

PBS Newshour: What you need to know about this year’s elevated flu threat

flu-vaccines

PBS Newshour last week had a segment about this year’s flu season, which doctors are warning could be more severe than normal. One reason for that is that one of the flu virus strains that is most prevalent is not responding as well as usual to the vaccine. LJ Tan explains: …with this upcoming season, we are getting a predominance of H3N2. That means we might have a more severe season. But not only that Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Mumps Outbreak in the NHL

NHL Hockey MN Wild Wings

Last week, the Wall Street Journal reported on The Measles Outbreak Coming Near You. Today we’re learning about another outbreak of a vaccine-preventable illness, this time hitting the National Hockey League. MyFoxNY reports that a mumps outbreak is affecting several NHL teams, with at least 9 players infected since November, five of them with the Minnesota Wild Wings. The latest teams with reported cases are the New York Rangers and the New Jersey Devils. MyFoxNY Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

WSJ: The Measles Outbreak Coming Near You

Wall Street Journal

We’ve written before about the disturbing rise in the prevalence of diseases that, thanks to vaccines, had once been considered eradicated or near-eradicated in the US. In today’s Wall Street Journal, Dr. Haider Javed Warraich, a physician at the Beth Israel Deaconess Medical Center in Boston and an instructor at Harvard Medical School, discusses the problem in depth: Measles is making a terrifying comeback in the U.S., with some 600 cases reported this year, more Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,